NCT03098082View on ClinicalTrials.gov

Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis

NACompletedINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

July 6, 2017

Primary Completion Date

April 8, 2020

Study Completion Date

April 8, 2020

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DEVICE

Actim Pancreatitis

Actim Pancreatitis (Medix Biochemica) is a urine trypsinogen-2 dipstick test (UTDT) that uses trypsinogen-2 as a biomarker for acute pancreatitis.

Trial Locations (1)

46202

Indiana University, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03098082 - Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis | Biotech Hunter | Biotech Hunter